X4 PHARMACEUTICALS INC
(98420X103)
ファンドの報告 X4 PHARMACEUTICALS INC 13F提出書類による
商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
---|---|---|---|---|---|
Orbimed Advisors LLC | 936,493 | $14,047k | Jun 30, 2019 | Aug 14, 2019 | |
RA Capital Management LLC | 861,393 | $12,921k | Jun 30, 2019 | Aug 14, 2019 | |
Deerfield Management Company LP Series C | 565,000 | $8,475k | Jun 30, 2019 | Aug 14, 2019 | |
SV Health Investors LLC | 311,490 | $4,672k | Jun 30, 2019 | Aug 14, 2019 | |
New LEAF Venture Partners LLC | 285,000 | $4,275k | Jun 30, 2019 | Aug 13, 2019 | |
First Eagle Investment Management LLC | 35,730 | $536k | Jun 30, 2019 | Aug 13, 2019 |